FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)

View source ↗

Summary

FDA approved the original application for a generic buprenorphine and naloxone product for the treatment of opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine and naloxone (BUPRENORPHINE AND NALOXONE)

Snippet

ORIG AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE)